2.62
price down icon3.32%   -0.09
 
loading
前日終値:
$2.71
開ける:
$2.725
24時間の取引高:
7.36M
Relative Volume:
2.50
時価総額:
$386.50M
収益:
$4.21M
当期純損益:
$-97.67M
株価収益率:
-2.8172
EPS:
-0.93
ネットキャッシュフロー:
$-70.76M
1週間 パフォーマンス:
-6.09%
1か月 パフォーマンス:
-3.68%
6か月 パフォーマンス:
-5.42%
1年 パフォーマンス:
-14.10%
1日の値動き範囲:
Value
$2.61
$2.748
1週間の範囲:
Value
$2.61
$2.86
52週間の値動き範囲:
Value
$2.01
$6.33

Absci Corp Stock (ABSI) Company Profile

Name
名前
Absci Corp
Name
セクター
Healthcare (1174)
Name
電話
(360) 949-1041
Name
住所
18105 SE MILL PLAIN BLVD, VANCOUVER
Name
職員
157
Name
Twitter
Name
次回の収益日
2025-03-18
Name
最新のSEC提出書
Name
ABSI's Discussions on Twitter

ABSI を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ABSI
Absci Corp
2.62 386.50M 4.21M -97.67M -70.76M -0.93
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Absci Corp Stock (ABSI) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-01-22 開始されました Needham Buy
2024-10-02 開始されました Guggenheim Buy
2024-07-03 開始されました Morgan Stanley Overweight
2024-03-14 開始されました Scotiabank Sector Outperform
2023-12-05 開始されました KeyBanc Capital Markets Overweight
2023-05-04 開始されました H.C. Wainwright Buy
2022-08-12 ダウングレード JP Morgan Overweight → Underweight
2022-07-18 開始されました Truist Buy
2022-03-02 再開されました Cowen Market Perform
2022-02-01 開始されました Berenberg Buy
2021-11-10 ダウングレード BofA Securities Neutral → Underperform
2021-10-15 再開されました Cowen Market Perform
2021-08-16 開始されました BofA Securities Neutral
2021-08-16 開始されました Cowen Market Perform
2021-08-16 開始されました Credit Suisse Outperform
2021-08-16 開始されました Stifel Hold
すべてを表示

Absci Corp (ABSI) 最新ニュース

pulisher
Jun 17, 2025

Millennium Management LLC Sells 1,149,603 Shares of Absci Co. (NASDAQ:ABSI) - MarketBeat

Jun 17, 2025
pulisher
Jun 16, 2025

Absci Co. (NASDAQ:ABSI) Given Average Rating of "Buy" by Brokerages - MarketBeat

Jun 16, 2025
pulisher
Jun 09, 2025

Transcript : Absci Corporation Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 08 - marketscreener.com

Jun 09, 2025
pulisher
Jun 03, 2025

Two Sigma Investments LP Raises Stock Position in Absci Co. (NASDAQ:ABSI) - MarketBeat

Jun 03, 2025
pulisher
Jun 03, 2025

Deutsche Bank AG Purchases 28,073 Shares of Absci Co. (NASDAQ:ABSI) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Absci (NASDAQ:ABSI) Rating Lowered to Sell at Wall Street Zen - MarketBeat

Jun 02, 2025
pulisher
Jun 01, 2025

Top 5 AI & Digital Biotech Companies (June 2025) - Securities.io

Jun 01, 2025
pulisher
Jun 01, 2025

Absci (NASDAQ:ABSI) Stock Rating Lowered by Wall Street Zen - Defense World

Jun 01, 2025
pulisher
May 28, 2025

AbSci Corp (ABSI) Sees Borrow Rate Increase | ABSI Stock News - GuruFocus

May 28, 2025
pulisher
May 27, 2025

Woodline Partners LP Decreases Position in Absci Co. (NASDAQ:ABSI) - MarketBeat

May 27, 2025
pulisher
May 27, 2025

Northern Trust Corp Has $1.72 Million Stock Holdings in Absci Co. (NASDAQ:ABSI) - Defense World

May 27, 2025
pulisher
May 27, 2025

Brokerages Set Absci Co. (NASDAQ:ABSI) Price Target at $8.40 - MarketBeat

May 27, 2025
pulisher
May 24, 2025

Wall Street Zen Upgrades Absci (NASDAQ:ABSI) to Hold - Defense World

May 24, 2025
pulisher
May 23, 2025

Ameriprise Financial Inc. Sells 23,668 Shares of Absci Co. (NASDAQ:ABSI) - Defense World

May 23, 2025
pulisher
May 22, 2025

AbSci Corp (ABSI): Key Indicator Shows Noticeable Increase | ABSI Stock News - GuruFocus

May 22, 2025
pulisher
May 21, 2025

Catherine Wood's Strategic Acquisition of Absci Corp Shares - GuruFocus

May 21, 2025
pulisher
May 20, 2025

Schonfeld Strategic Advisors LLC Has $144,000 Stake in Absci Co. (NASDAQ:ABSI) - MarketBeat

May 20, 2025
pulisher
May 20, 2025

Absci to Participate in Upcoming Investor Conferences - GlobeNewswire

May 20, 2025
pulisher
May 20, 2025

Absci Sets Stage for Major AI Breakthroughs at Goldman Sachs and Jefferies Healthcare Conferences - Stock Titan

May 20, 2025
pulisher
May 19, 2025

Needham & Company LLC Reiterates Buy Rating for Absci (NASDAQ:ABSI) - MarketBeat

May 19, 2025
pulisher
May 19, 2025

Price T Rowe Associates Inc. MD Increases Holdings in Absci Co. (NASDAQ:ABSI) - Defense World

May 19, 2025
pulisher
May 17, 2025

Absci Co. (NASDAQ:ABSI) Shares Sold by Stifel Financial Corp - Defense World

May 17, 2025
pulisher
May 16, 2025

Needham & Company LLC Reaffirms “Buy” Rating for Absci (NASDAQ:ABSI) - Defense World

May 16, 2025
pulisher
May 15, 2025

Absci Corp’s Earnings Call: A Promising Outlook - TipRanks

May 15, 2025
pulisher
May 15, 2025

Absci Corporation (NASDAQ:ABSI) Q1 2025 Earnings Call Transcript - Insider Monkey

May 15, 2025
pulisher
May 15, 2025

Absci First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Dimensional Fund Advisors LP Acquires 241,779 Shares of Absci Co. (NASDAQ:ABSI) - Defense World

May 15, 2025
pulisher
May 14, 2025

ABSI: Needham Reiterates Buy Rating and $9 Price Target | ABSI Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Absci (ABSI) Initiates Phase 1 Study of AI-Designed Antibody ABS-101 | ABSI Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Absci (ABSI) Launches First Human Trial for ABS-101 - GuruFocus

May 14, 2025
pulisher
May 14, 2025

ABSI: Needham Reiterates Buy Rating and $9 Price Target | ABSI S - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Assessing Absci: Insights From 6 Financial Analysts - Benzinga

May 14, 2025
pulisher
May 14, 2025

Why Everus Construction Group Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Benzinga

May 14, 2025
pulisher
May 14, 2025

Absci Corporation Advances Clinical Programs with Strong Q1 Results - TipRanks

May 14, 2025
pulisher
May 14, 2025

Fred Alger Management LLC Reduces Position in Absci Co. (NASDAQ:ABSI) - MarketBeat

May 14, 2025
pulisher
May 13, 2025

Absci Corp Q1 2025 Earnings: EPS Beats Estimates at -$0.21, Reve - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Absci earnings beat by $0.01, revenue fell short of estimates - Investing.com

May 13, 2025
pulisher
May 13, 2025

Earnings call transcript: Absci Q1 2025 sees stock surge post-earnings By Investing.com - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

AbSci (ABSI) Anticipates Significant Post-Earnings Movement | AB - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Earnings call transcript: Absci Q1 2025 sees stock surge post-earnings - Investing.com

May 13, 2025
pulisher
May 13, 2025

Absci Q1 2025 Earnings Call Transcript - MarketBeat

May 13, 2025
pulisher
May 13, 2025

Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

Absci Corp reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2025
pulisher
May 13, 2025

ABSI Surprises with Q1 Revenue Beat and Expands Clinical Initiat - GuruFocus

May 13, 2025
pulisher
May 13, 2025

ABSI Surprises with Q1 Revenue Beat and Expands Clinical Initiatives | ABSI Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Absci reports first participants dosed in Phase 1 ABS-101 trial - TipRanks

May 13, 2025
pulisher
May 13, 2025

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results - GlobeNewswire

May 13, 2025
pulisher
May 13, 2025

Absci Announces First Participants Dosed In Phase 1 Clinical Trial Of Abs-101, A Potential Best-In-Class Anti-TL1a Antibody For The Treatment Of Inflammatory Bowel Disease - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease - GlobeNewswire

May 13, 2025
pulisher
May 13, 2025

Breakthrough: First-Ever AI-Designed IBD Treatment Begins Human Trials with Quarterly Dosing Potential - Stock Titan

May 13, 2025
pulisher
May 12, 2025

What To Expect From Absci Corp (ABSI) Q1 2025 Earnings - GuruFocus

May 12, 2025

Absci Corp (ABSI) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
大文字化:     |  ボリューム (24 時間):